Pharmaniaga on track to fullfil vaccine supply

Pharmaniaga group managing director Datuk Zulkarnain Md Eusope

PUCHONG: Pharmaniaga Bhd is on track to meet its contractual obligation to the Government ahead of the agreed delivery schedule by supplying both filled and finished as well as finished Sinovac Covid-19 vaccine.

In a statement Wednesday, the pharmaceutical company said it would be able to supply a total of 8.6 million doses by end June 2021.

“Pharmaniaga’s wholly-owned subsidiary Pharmaniaga LifeScience Sdn Bhd (PLS) is also ready to ramp up production from 2 million to 4 doses a month in order to help the Government expedite the vaccination programme and achieve herd immunity,” it said.

Group managing director Datuk Zulkarnain Md Eusope said up to May 23, PLS’s high-tech plant had completed fill and finish manufacturing a total of 1.88 million doses of Sinovac Covid-19 doses.

“From the total completed doses, the EU certified plant has rolled out a total of 290,480 doses to the Health Ministry on May 11, which was from the 200L of bulk vaccine received in February for process validation.

“320,000 doses are awaiting approval from the National Pharmaceutical Regulatory Authority (NPRA) before it is ready to be distributed and administered for use of Rakyat. This stringent process for every batch of vaccine production is required for approval called Lot Release by the NPRA. Whilst 319,320 doses in the process of delivery,” he said.

Meanwhile, the remaining 960,000 doses are undergoing 12 quality control tests before the Lot Release process for NPRA approval which is expected to be completed by the end of this month.

“And the plant is expected to fill and finish 720,000 doses which it has carried out since last Sunday and to be completed by May 31, then will undergo 12 quality control tests. Accumulatively, PLS will have 2.6 million doses of vaccine by the end of May 2021,” Zulkarnain said.

In addition, Pharmaniaga has also received 1 million doses of finished vaccine from Sinovac in Beijing, China which has been approved for its Lot Release by the NPRA.

Altogether, the combination of finished vaccine from China and filled and finished vaccine has reached a total of more than 3.6 million in May alone.

“Upon completion of our obligation to the Government, we can start offering the Sinovac Covid-19 vaccine to the private sector,” Zulkarnain said.

He added that Pharmaniaga intends to import 10 million doses of Sinovac Covid-19 finished vaccine from China.

“Taking into consideration the current geopolitics and supply issues around the world, the supply of vaccines is unpredictable and there could be a possibility of vaccine supply shortage in Malaysia if this happens.

“World Health Organisation is expected to approve the Sinovac Covid-19 vaccine very soon and we foresee that once it happens, the global demand for Sinovac will spike and we may not be able to obtain it easily like now. Thus we plan to place the order now before that occurs,” he said.

Article type: metered
User Type: anonymous web
User Status:
Campaign ID: 46
Cxense type: free
User access status: 3
Join our Telegram channel to get our Evening Alerts and breaking news highlights

Next In Business News

FBM KLCI continues slide for 6th straight day
Pekat Group’s RE project in Pulau Tioman wins award in National Energy programme
AmInvest Research retains overweight on telcos, buy call on Telekom
Ringgit falls against US$ ahead of FOMC meeting next week
Quick take: BSL rises 8.4%, hit record high
FBM KLCI opens on a flattish note
Quick take: Pasukhas rises on RM77mil new contract
Trading ideas: MSM, Pasukhas, CMSB and Tri-Mode
Fed's Powell orders sweeping ethics review after officials' trading prompts outcry
Chip supply, testing woes to further curb light vehicle production in 2021

Stories You'll Enjoy